Smerat, TA; Sinokrot, H; Najjar, A; Karaman, R
(Molecules, 2017-10-26)
Abstract
Background: Poor pharmacokinetic profiles and resistance are the main two drawbacks from which currently used antiviral agents suffer, thus make them excellent targets for research, especially in the presence of ...